,

Nahide Zeren Arda Ozturk1, Oliwia Barbara Majchrzak2, Gianluca Ulivi2

  • 1Fenerbahce University Faculty of Pharmacy, Pharmaceutical Technology Department, Istanbul, Turkey; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, Switzerland; School of Pharmaceutical Sciences, University of Geneva, 1 Rue Michel Servet, 1211 Geneva, Switzerland; Ege University Faculty of Pharmacy, Pharmaceutical Technology Department, Izmir, Turkey.

概括

完全合成的外体模拟剂 (FSEM) 在黑色素瘤治疗中同时提供EGCG和miR-23a. 与脂质体相比,这些新型药物载体显示选择性杀死癌细胞并降低毒性.